Skip to content
  • 2023 CATALOGS
  • NEWSROOM
    • Latest News
    • Publications
    • Press Releases
    • Videos
    • Posters
    • Conferences
  • CONTACT
    • General Inquiries
    • Customer Support
    • Technical Support
    • Global Distributor Support
  • CAREERS
  • LabPMM
    • LabPMM, LLC (USA)
    • LabPMM, GmbH (Germany)
    • LabPMM, GK (Japan)
  • MY ACCOUNT
    • Login
    • Create Account
Invivoscribe Logo Invivoscribe Logo Invivoscribe Logo
  • PRODUCTS
    • Next-Generation Sequencing
      • CE-IVD
        • Illumina®
        • Thermo Fisher®
      • RUO
        • Illumina®
        • Thermo Fisher®
      • MRD Clonality
      • FLT3 ITD MRD
      • NPM1 MRD
    • Companion Diagnostics (CDx)
      • LeukoStrat® CDx FLT3
         Mutation Assay
      • CE-IVD
      • CE-IVDR
      • IVD (US)
      • IVD (JP)
    • ABI Fluorescence Detection
      • CE-IVD
        • Clonality
        • FLT3
      • RUO
        • Clonality
        • FLT3
        • Translocations
    • Gel Detection
      • CE-IVD
        • Clonality
      • RUO
        • Clonality
        • FLT3
        • Translocations
    • Controls
      • Master Mix Controls
      • DNA Controls
      • RNA Controls
      • MRD Controls
    • Software
      • Dockerized
        • FLT3 ITD MRD
        • NPM1 MRD
        • LymphoTrack® Enterprise Software – MiSeq™
    • Reagents
      • ASRs
      • Enzymes
      • Hi-Di Formamide
    • 2023 Product Catalog
  • CLINICAL LAB SERVICES
    • Clinical Lab Services Overview

      The Laboratory for Personalized Molecular Medicine® (LabPMM®) at Invivoscribe offer internationally standardized testing of novel and proprietary biomarkers that are critically important for patient care.

      EXPLORE SERVICES ⟶
    • Companion Diagnostic (CDx) Tests
      • CDx – USA
      • CDx – Germany
      • CDx – Japan
    • NGS Cancer Panels
      • MyAML
      • MyMRD
    • MFC Panels
      • Hematolymphoid Screening Panel
      • AML MRD Assay
      • CLL MRD Assay
    • MRD NGS Tests
      • Clonality
      • FLT3 ITD
      • NPM1
    • Clonality NGS Tests
      • SHM
      • IGH
      • IGK
      • TRG
      • TRB
    • Targeted Genes
      • FLT3
      • NPM1
    • Custom Assays
    • Licensure and Certifications
    • 2023 Services Catalog
  • DISEASES
    • Lymphoid
      Mature B-cell
      Mature T-cell

      Lymphoma

      Lymphoma is a cancer that starts in cells that are part of the body’s immune system. Knowing which type of lymphoma you have is important because it affects your treatment options and your outlook (prognosis).

      LEARN MORE ⟶



    • Myeloid
      Myelodysplastic Syndromes (MDS)
      Acute Myeloid Leukemia (AML)
      Myeloproliferative Neoplasms (MPNs)

      Myeloma

      Multiple myeloma is a cancer of plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system.

      LEARN MORE ⟶



    • Hematological Testing Menu

      Browse our comprehensive menu of product & testing services.

      EXPLORE MENU ⟶
  • PARTNERSHIPS
    • Partnerships Overview

      A proven strategy to accelerate drug approvals

      EXPLORE PARTNERSHIPS ⟶
    • Product Development

      Design Controls, Bioinformatics Software, Identify & Track, Custom Development, and Complementary MRD Assays

      EXPLORE ⟶
    • Manufacturing

      cGMP Compliant, CE-marked IVDs & CDx Manufacturing, Assay Development, and Controls & Reagents

      EXPLORE ⟶
    • LabPMM®

      Clinical Lab Experience, Internationally Standardized, Comprehensive Panels, Complementary MRD Assays, and Worldwide Enrollment

      EXPLORE ⟶
    • Global Regulatory Expertise

      Accredited & Proven, Registered Medical Device Establishment, Multiple CDx Approvals, CE-marked IVDs, and Marketing Authorization Holder (MAH)

      EXPLORE ⟶
  • SCIENCE
    • Science Overview

      We take pride in expanding the science that bridges personalized medicine with quality healthcare.

      EXPLORE OUR SCIENCE ⟶
    • Personalized Medicine

      Personalized Molecular Medicine® is use of genomics and patient specific information to identify optimal treatment for each patient.

      EXPLORE PERSONALIZED MEDICINE ⟶
  • PUBLICATIONS
    • Featured Publication

      November 17th, 2020
      Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

      VIEW PUBLICATION ⟶
    • Latest Publications

      April 20th, 2021
      Validation of a Next-Generation Sequencing-based T-Cell Receptor Gamma Gene Rearrangement Diagnostic Assay: Transitioning from Capillary Electrophoresis to Next-Generation Sequencing

      VIEW PUBLICATION ⟶

      November 17th, 2020
      Routine Evaluation of Minimal Residual Disease in Myeloma Using Next-Generation Sequencing Clonality Testing

      VIEW PUBLICATION ⟶
      VIEW ALL PUBLICATIONS ⟶
  • COMPANY
    • Company
      • About Us
      • Leadership Team
      • Board of Directors
      • Newsroom
      • Global Distributors
      • Licensure and Certifications
      • Careers & Culture
      • Shop Corporate Gear
    • Invivoscribe Locations
       
      Invivoscribe, Inc. (USA)
      San Diego, CA, US
      CONTACT US ⟶
       
      Invivoscribe, SARL (France)
      Marseille, France
      CONTACT US ⟶
       
      Invivoscribe Diagnostic Technologies,(Shanghai) Co.,Ltd.
      Shanghai, China
      CONTACT US ⟶
    • Clinical Lab Locations
       
      LabPMM, LLC (USA)
      San Diego, CA, US
      CONTACT US ⟶
       
      LabPMM, GmbH (Germany)
      Munich, Germany
      CONTACT US ⟶
       
      LabPMM, GK (Japan)
      Kawasaki, Japan
      CONTACT US ⟶
       
      Invivoscribe Diagnostic Technologies,(Shanghai) Co.,Ltd.
      Shanghai, China
      CONTACT US ⟶
    • Support
       
      Invivoscribe, Inc. (USA)
      CONTACT US ⟶
       
      Invivoscribe, SARL (France)
      CONTACT US ⟶
       
      Invivoscribe Diagnostic Technologies,(Shanghai) Co.,Ltd.
      CONTACT US ⟶
       
      LabPMM, LLC (USA)
      CONTACT US ⟶
       
      LabPMM, GmbH (Germany)
      CONTACT US ⟶
       
      LabPMM, GK (Japan)
      CONTACT US ⟶
  • Search
    • Search Articles & Publications
    • Search Products & Services
      SEARCH ⟶
       
    • Search Product Documents & IFUs
      SEARCH ⟶
       
  • PRODUCTS
    • Explore Products
    • Search Products
    • Search Product Documents & IFUs
    • Next-Generation Sequencing
      • CE-IVD
        • Illumina®
        • Thermo Fisher®
      • RUO
        • Illumina®
        • Thermo Fisher®
      • MRD Clonality
      • FLT3 ITD MRD
      • NPM1 MRD
    • Companion Diagnostics (CDx)
      • LeukoStrat® CDx FLT3
        Mutation Assay
      • CE-IVD
      • CE-IVDR
      • IVD (US)
      • IVD (JP)
    • ABI Fluorescence Detection
      • CE-IVD
        • Clonality
        • FLT3
      • RUO
        • Clonality
        • FLT3
        • Translocations
    • Gel Detection
      • CE-IVD
        • Clonality
      • RUO
        • Clonality
        • FLT3
        • Translocations
    • Controls
      • Master Mix Controls
      • DNA Controls
      • RNA Controls
      • MRD Controls
    • Software
      • Dockerized
        • FLT3 ITD MRD
        • NPM1 MRD
        • LymphoTrack® Enterprise Software – MiSeq™
    • Reagents
      • ASRs
      • Enzymes
      • Hi-Di Formamide
    • 2023 Products Catalog
  • CLINICAL LAB SERVICES
    • Clinical Lab Services Overview
    • Companion Diagnostic (CDx) Tests
      • CDx – USA
      • CDx – Germany
      • CDx – Japan
    • NGS Cancer Panels
      • MyAML
      • MyMRD
    • MRD NGS Tests
      • Clonality
      • FLT3 ITD
      • NPM1
    • Clonality NGS Tests
      • SHM
      • IGH
      • IGK
      • TRG
      • TRB
    • Targeted Genes
      • FLT3
      • NPM1
    • Custom Assays
    • Licensure and Certifications
    • 2023 Services Catalog
  • MFC Panels
    • Hematolymphoid Screening Panel
    • AML MRD Assay
    • CLL MRD Assay
  • DISEASES
    • Lymphoid
      Mature B-cell
      Mature T-cell

      Lymphoma

      Lymphoma is a cancer that starts in cells that are part of the body’s immune system. Knowing which type of lymphoma you have is important because it affects your treatment options and your outlook (prognosis).

      LEARN MORE ⟶



      • Mature B-cell
      • Mature T-cell
    • Myeloid
      Myelodysplastic Syndromes (MDS)
      Acute Myeloid Leukemia (AML)
      Myeloproliferative Neoplasms (MPNs)

      Myeloma

      Multiple myeloma is a cancer of plasma cells. Normal plasma cells are found in the bone marrow and are an important part of the immune system.

      LEARN MORE ⟶



      • Myelodysplastic Syndromes (MDS)
      • Acute Myeloid Leukemia (AML)
      • Myeloproliferative Neoplasms (MPNs)
    • Hematological Testing Menu

      Browse our comprehensive menu of product & testing services.

      EXPLORE MENU ⟶
  • PARTNERSHIPS
    • Partnerships Overview
    • Product Development
    • Manufacturing
    • LabPMM®
    • Global Regulatory Expertise
  • SCIENCE
    • Science Overview
    • Personalized Medicine
  • PUBLICATIONS
    • Featured Publication
    • Latest Publications
  • NEWSROOM
    • Latest News
    • Publications
    • Press Releases
    • Videos
    • Posters
    • Conferences
  • CAREERS & CULTURE
  • COMPANY
    • Support
    • Company
      • About Us
      • Leadership Team
      • Board of Directors
      • Newsroom
      • Global Distributors
      • Licensure and Certifications
      • Shop Corporate Gear
    • Invivoscribe Locations
      • Invivoscribe, Inc. (USA)
      • Invivoscribe, SARL (France)
      • Invivoscribe Diagnostic Technologies (Shanghai) Co., Ltd.
    • Clinical Lab Locations
      • LabPMM, LLC (USA)
      • LabPMM, GmbH (Germany)
      • LabPMM, GK (Japan)
      • Invivoscribe Diagnostic Technologies (Shanghai) Co., Ltd.
Next-Generation SequencingInvivoscribe Marketing2019-07-18T22:57:04-07:00

Title

  • PRODUCTS
    • Next-Generation Sequencing
      • CE-IVD
        • Illumina®
        • Thermo Fisher®
      • RUO
        • Illumina®
        • Thermo Fisher®
      • MRD Clonality
      • FLT3 ITD MRD
      • NPM1 MRD
    • Companion Diagnostics (CDx)
      • LeukoStrat® CDx FLT3
         Mutation Assay
      • CE-IVD
      • CE-IVDR
      • IVD (US)
      • IVD (JP)
    • ABI Fluorescence Detection
      • CE-IVD
        • Clonality
        • FLT3
      • RUO
        • Clonality
        • FLT3
        • Translocations
    • Gel Detection
      • CE-IVD
        • Clonality
      • RUO
        • Clonality
        • FLT3
        • Translocations
    • Controls
      • Master Mix Controls
      • DNA Controls
      • RNA Controls
      • MRD Controls
    • Software
      • Dockerized
        • FLT3 ITD MRD
        • NPM1 MRD
        • LymphoTrack® Enterprise Software – MiSeq™
    • Reagents
      • ASRs
      • Enzymes
      • Hi-Di Formamide
    • 2023 Product Catalog
  • CLINICAL LAB SERVICES
    • Clinical Lab Services Overview
    • Companion Diagnostic (CDx) Tests
      • CDx – USA
      • CDx – Germany
      • CDx – Japan
    • NGS Cancer Panels
      • MyAML
      • MyMRD
    • MFC Panels
      • Hematolymphoid Screening Panel
      • AML MRD Assay
      • CLL MRD Assay
    • MRD NGS Tests
      • Clonality
      • FLT3 ITD
      • NPM1
    • Clonality NGS Tests
      • SHM
      • IGH
      • IGK
      • TRG
      • TRB
    • Targeted Genes
      • FLT3
      • NPM1
    • Custom Assays
    • Licensure and Certifications
    • 2023 Services Catalog
  • DISEASES
    • Lymphoid
    • Myeloid
    • Hematological Testing Menu
  • PARTNERSHIPS
    • Partnerships Overview
    • Product Development
    • Manufacturing
    • LabPMM®
    • Global Regulatory Expertise
  • SCIENCE
    • Science Overview
    • Personalized Medicine
  • PUBLICATIONS
    • Featured Publication
    • Latest Publications
  • COMPANY
    • Company
      • About Us
      • Leadership Team
      • Board of Directors
      • Newsroom
      • Global Distributors
      • Licensure and Certifications
      • Careers & Culture
      • Shop Corporate Gear
    • Invivoscribe Locations
    • Clinical Lab Locations
    • Support
  • Search
    • Search Articles & Publications
    • Search Products & Services
    • Search Product Documents & IFUs

INVIVOSCRIBE

 
Invivoscribe, Inc. (USA)
San Diego, CA, US
CONTACT US ⟶
 
Invivoscribe, SARL (France)
Marseille, France
CONTACT US ⟶
 
Invivoscribe Diagnostic Technologies, (Shanghai) Co., Ltd.
Shanghai, China
CONTACT US ⟶

CLINICAL LAB LOCATIONS

 
LabPMM, LLC (USA)
San Diego, CA, US
CONTACT US ⟶
 
LabPMM, GmbH (Germany)
Munich, Germany
CONTACT US ⟶
 
LabPMM, GK (Japan)
Kawasaki, Japan
CONTACT US ⟶
 
Invivoscribe Diagnostic Technologies, (Shanghai) Co., Ltd.
Shanghai, China
CONTACT US ⟶

PRIVACY/TERMS & CONDITIONS

Terms and Conditions

Web Privacy Policy

Cookie Policy

Licensure and Certifications

Global Distributors

CONNECT

Genection™
© 2018 -    |   Invivoscribe, Inc. |   All Rights Reserved

Global Search

SEARCH BY KEYWORD

Global Search

SEARCH BY KEYWORD

Looking for Product Documents?
Try our New Document Search Feature ⟶

Looking for Product Documents?
Try our New Document Search Feature ⟶
  • PRODUCTS
    • Explore Products
    • Search Products
    • Search Product Documents & IFUs
    • Next-Generation Sequencing
      • CE-IVD
        • Illumina®
        • Thermo Fisher®
      • RUO
        • Illumina®
        • Thermo Fisher®
      • MRD Clonality
      • FLT3 ITD MRD
      • NPM1 MRD
    • Companion Diagnostics (CDx)
      • LeukoStrat® CDx FLT3
        Mutation Assay
      • CE-IVD
      • CE-IVDR
      • IVD (US)
      • IVD (JP)
    • ABI Fluorescence Detection
      • CE-IVD
        • Clonality
        • FLT3
      • RUO
        • Clonality
        • FLT3
        • Translocations
    • Gel Detection
      • CE-IVD
        • Clonality
      • RUO
        • Clonality
        • FLT3
        • Translocations
    • Controls
      • Master Mix Controls
      • DNA Controls
      • RNA Controls
      • MRD Controls
    • Software
      • Dockerized
        • FLT3 ITD MRD
        • NPM1 MRD
        • LymphoTrack® Enterprise Software – MiSeq™
    • Reagents
      • ASRs
      • Enzymes
      • Hi-Di Formamide
    • 2023 Products Catalog
  • CLINICAL LAB SERVICES
    • Clinical Lab Services Overview
    • Companion Diagnostic (CDx) Tests
      • CDx – USA
      • CDx – Germany
      • CDx – Japan
    • NGS Cancer Panels
      • MyAML
      • MyMRD
    • MRD NGS Tests
      • Clonality
      • FLT3 ITD
      • NPM1
    • Clonality NGS Tests
      • SHM
      • IGH
      • IGK
      • TRG
      • TRB
    • Targeted Genes
      • FLT3
      • NPM1
    • Custom Assays
    • Licensure and Certifications
    • 2023 Services Catalog
  • MFC Panels
    • Hematolymphoid Screening Panel
    • AML MRD Assay
    • CLL MRD Assay
  • DISEASES
    • Lymphoid
      • Mature B-cell
      • Mature T-cell
    • Myeloid
      • Myelodysplastic Syndromes (MDS)
      • Acute Myeloid Leukemia (AML)
      • Myeloproliferative Neoplasms (MPNs)
    • Hematological Testing Menu
  • PARTNERSHIPS
    • Partnerships Overview
    • Product Development
    • Manufacturing
    • LabPMM®
    • Global Regulatory Expertise
  • SCIENCE
    • Science Overview
    • Personalized Medicine
  • PUBLICATIONS
    • Featured Publication
    • Latest Publications
  • NEWSROOM
    • Latest News
    • Publications
    • Press Releases
    • Videos
    • Posters
    • Conferences
  • CAREERS & CULTURE
  • COMPANY
    • Support
    • Company
      • About Us
      • Leadership Team
      • Board of Directors
      • Newsroom
      • Global Distributors
      • Licensure and Certifications
      • Shop Corporate Gear
    • Invivoscribe Locations
      • Invivoscribe, Inc. (USA)
      • Invivoscribe, SARL (France)
      • Invivoscribe Diagnostic Technologies (Shanghai) Co., Ltd.
    • Clinical Lab Locations
      • LabPMM, LLC (USA)
      • LabPMM, GmbH (Germany)
      • LabPMM, GK (Japan)
      • Invivoscribe Diagnostic Technologies (Shanghai) Co., Ltd.
LATEST NEWS
Invivoscribe Announces Key Submission in the EU⟶

CONNECT